Dimensional Fund Advisors LP boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 107.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,486,643 shares of the company’s stock after buying an additional 769,333 shares during the quarter. Dimensional Fund Advisors LP owned 1.69% of Acadia Healthcare worth $73,412,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after buying an additional 270 shares during the period. Riverhead Capital Management LLC acquired a new position in Acadia Healthcare during the second quarter worth about $209,000. Paloma Partners Management Co acquired a new position in Acadia Healthcare during the first quarter worth about $217,000. M&T Bank Corp acquired a new position in Acadia Healthcare during the first quarter worth about $230,000. Finally, World Asset Management Inc acquired a new position in Acadia Healthcare during the second quarter worth about $242,000.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at 44.02 on Tuesday. The stock has a market cap of $3.87 billion, a P/E ratio of 483.74 and a beta of 1.07. Acadia Healthcare Company, Inc. has a one year low of $32.54 and a one year high of $54.34. The firm has a 50 day moving average of $46.58 and a 200 day moving average of $46.38.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Acadia Healthcare Company, Inc. (ACHC) Holdings Lifted by Dimensional Fund Advisors LP” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/10/10/acadia-healthcare-company-inc-achc-holdings-lifted-by-dimensional-fund-advisors-lp.html.

In other news, CEO Joey A. Jacobs sold 500,000 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $25,345,000.00. Following the transaction, the chief executive officer now owns 201,496 shares of the company’s stock, valued at approximately $10,213,832.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Brent Turner sold 206,252 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now directly owns 81,106 shares in the company, valued at approximately $4,111,263.14. The disclosure for this sale can be found here. Insiders sold a total of 3,085,693 shares of company stock worth $157,729,099 in the last ninety days. Corporate insiders own 11.10% of the company’s stock.

ACHC has been the topic of several recent analyst reports. BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 1st. Deutsche Bank AG upped their target price on shares of Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a research report on Monday, July 31st. Craig Hallum restated a “buy” rating and set a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Mizuho upped their target price on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Finally, Zacks Investment Research lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $56.90.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.